LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...

Paris, France - Enoxaparin (Lovenox, Sanofi-Aventis) seems to be associated with a lower risk of cardiovascular outcomes compared with unfractionated heparin (UFH) in patients with STEMI undergoing ...

Lovenox (enoxaparin) is a prescription drug used to prevent or treat certain types of blood clots. Lovenox’s cost may depend on factors such as your dosage, whether you have health insurance, and how ...

The authors looked only at TIMI 11B patients for whom data on aPTT had been collected (n=1893) and compared the number of events and bleeding rates after 48 hours in patients on UFH to patients who ...

Sanofi-Aventis has won FDA priority review for a new indication for its blockbuster blood thinner Lovenox.The FDA will review Lovenox for treatment of patients suffering acute ST-segment elevation ...

Techdow USA is introducing 30 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg and 150 mg strengths of generic Enoxaparin Sodium (Preservative Free) Prefilled Syringes, which is the generic of Sanofi-Aventis’ ...

(Reuters) - The U.S. Food and Drug Administration issued a new warning on the use of the anticoagulant Lovenox in patients fitted with a spinal catheter because of the risk of spinal column bleeding ...

Shares of Momenta took a hit after the company warned that its development of a generic version of Sanofi's blood thinner Lovenox is likely to take longer than expected. Shares slid 15 percent on the ...

You know those movie scenes in which our hero is moving downriver in a boat, only to suddenly happen upon an enormous waterfall? We have to watch while the hero frantically paddles upstream or makes ...

Jerusalem, Israel, January 25, 2011 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has received correspondence from the U.S. Food and Drug Administration (FDA) regarding ...